JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Miranda, P.
Right arrow Articles by Elion, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Miranda, P.
Right arrow Articles by Elion, G. B.

The metabolic disposition of 14C-azathioprine in the dog

P de Miranda, LM Beacham , TH Creagh and GB Elion

The metabolic disposition of the methylnitroimidazole moiety of azathioprine, labeled with 14C in carbons 4 and 5 of this imidazole ring, was investigated in the dog. The administration of the radioactive drug (10 mg/kg p.o.) was followed, after absorption, by a rapid uptake of the radioactivity into the blood cells, with subsequent redistribution to the plasma. The total urinary excretion of 14C was 41.6% in 32 hours. Anion exchange and high-pressure liquid chromatography of the urine revealed a large number of 14C-containing metabolites. These included unmetabolized azathioprine, 1-methyl-4- nitro-5-(N-acetyl-S-cysteinyl)imidazole, 1-methyl-4-nitro-5- thioimidazole and several compounds with ultraviolet absorption spectra similar to 5-substituted amino-1-methyl-4-nitroimidazoles. The most prominent of these was a highly acidic metabolite which was found to be identical in chemical, chromatographic and spectral properties with N,N'-[5-(1-METHYL-4-NITRO)IMIDAZOLYL]CYSTINE. This metabolite as well as 1-methyl-4-nitro-5-(N-acetyl-S-cysteinyl)imidazole and 1-methyl-4- nitro-5-thioimidazole were also identified in the urine of a dog given 1-methyl-4-nitro-5-(S-glutathionyl)-imidazole (10 mg/kg i.v.) suggesting that the latter compound is an intermediate in the formation of these urinary metabolites. The profile of the methylnitroimidazole urinary metabolites in the dog was similar to that in man and different from that in the rat. A metabolic pathway for the formation of these metabolites in the dog is proposed.

Volume 195, Issue 1, pp. 50-57, 10/01/1975
Copyright © 1975 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
ScienceHome page
G. Elion
The purine path to chemotherapy
Science, April 7, 1989; 244(4900): 41 - 47.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics.